SLC7A11/xCT Rekombinanter Antikörper

SLC7A11/xCT Rekombinant Antikörper für IF/ICC, FC (Intra), Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

IF/ICC, FC (Intra), Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

230227C5

Kat-Nr. : 82115-2-PBS

Synonyme

SLC7A11, xCT, 230227C5, Amino acid transport system xc, Amino acid transport system xc-



Geprüfte Anwendungen

Produktinformation

82115-2-PBS bindet in IF/ICC, FC (Intra), Indirect ELISA SLC7A11/xCT und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen SLC7A11/xCT fusion protein Ag25431
Vollständiger Name solute carrier family 7, (cationic amino acid transporter, y+ system) member 11
Berechnetes Molekulargewicht 55 kDa
GenBank-ZugangsnummerBC012087
Gene symbol SLC7A11
Gene ID (NCBI) 23657
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

SLC7A11 (also known as xCT) is a membrane transporter involved in the uptake of cystine. It promotes glutathione synthesis through the uptake of cystine and the concomitant release of glutamate. This, in turn, protects cells from oxidative stress, maintains cellular redox balance, and prevents cell death induced by lipid peroxidation. SLC7A11 has been identified as a potential target for cancer therapeutics. It is overexpressed in multiple malignant tumors and is closely associated with the growth, prognosis, metastasis, and treatment response of various cancers including lung cancer.